GlassScriptPhysician profile
Sookwook Lee
NPI 1619137932
$1,936.14
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $198 · 2021: $189 · 2022: $368 · 2023: $155 · 2024: $27.58 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.50 | 2019-2023 | |
| Amgen INC. | $425.29 | 2019-2022 | |
| Amarin Pharma, INC. | $242.73 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.96 | 2020-2023 | Xifaxan, Trulance |
| Phathom Pharmaceuticals, INC. | $137.80 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $81.95 | 2019 | |
| Vivus LLC | $70.99 | 2022-2023 | Qsymia |
| Horizon Therapeutics Plc | $41.42 | 2019-2020 | |
| Pfizer INC. | $32.55 | 2019 | |
| Lilly USA, LLC | $27.58 | 2024 | Mounjaro, Zepbound |
| Bavarian Nordic A/S | $22.90 | 2025 | Vaxchora, Vivotif |
| Genentech USA, INC. | $18.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sookwook Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.